Long Noncoding RNA AATBC Promotes the Proliferation and Migration of Prostate Cancer Cell Through miR-1245b-5p/CASK Axis
Wenyuan Zhang,Qionghong Liu,Jun Zhao,Tiejun Wang,Jinshan Wang
DOI: https://doi.org/10.2147/CMAR.S310529
2021-06-28
Cancer Management and Research
Abstract:Wenyuan Zhang, 1 Qionghong Liu, 2 Jun Zhao, 1 Tiejun Wang, 2 Jinshan Wang 2 1 Department of Urology, East Hospital, Ji'an Hospital, Jiangxi, 343000, People's Republic of China; 2 Department of Urology, East Hospital, Tongji University School of Medicine, Shanghai, 200123, People's Republic of China Correspondence: Jinshan Wang Department of Urology, East Hospital, Tongji University School of Medicine, Shanghai, 200123, People's Republic of China Email Introduction: Long noncoding RNAs (lncRANs) as suppressive or oncogenic genes have been substantiated in prostate cancer (PCa). In the current study, the role and molecular mechanism of lncRNA AATBC in the progression of PCa was evaluated. Methods: LncRNA AATBC and miR-1245b-5p expression were evaluated using RT-qPCR. CCK-8, colony-formation, apoptosis and transwell assay were used to analyze the in vitro role. The xenograft model was used to explore the in vivo role. Bioinformatics analysis and a dual luciferase assay, RIP and RNA pull down were used to confirm the interaction between lncRNA AATBC and 1245b-5p, as well as 1245b-5p and CASK. Results: Firstly, we certified that the expression of AATBC was augmented in PCa, and knockdown of AATBC could significantly inhibit the growth of PCa in vitro and in vivo. Mechanistically, our results manifested that AATBC could directly bind to miR-1245b-5p. In addition, miR-1245b-5p played cancer-suppressive role in PCa cells. Moreover, CASK was attested as the target of miR-1245b-5p, and CASK was demonstrated to exert as oncogene in the progression of PCa. Finally, rescue assays illustrated that miR-1245b-5p downregulation or CASK restoration could greatly resist the restrained effects of AATBC knockdown on PCa progression. Conclusion: AATBC could accelerate the progression of PCa through regulating miR-1245b-5p/CASK axis, which provided a potential therapeutic target for PCa treatment. Keywords: lncRNA, prostate cancer, AATBC, miR-1245b-5p, CASK Prostate cancer (PCa) is one of the most common and fatal malignancies in men worldwide, and the incidence increases significantly with age. 1 Patients with early PCa can achieve a good prognosis after systemic androgen deprivation therapy or hormonal therapy, surgical resection. 2 However, patients with advanced PCa often have a significant decrease in survival time and quality of life because of metastasis, recurrence and drug resistance. 2 , 3 It is therefore essential to carry out comprehensive exploration and mine novel molecular mechanisms in order to find new targets for the treatment of PCa. Voluminous studies have spotted that non-coding RNAs impersonate a sizeable role in tumor formation and progression, including small noncoding RNAs and long noncoding RNAs (lncRANs), both of which are a class of non-coding RNAs without protein-coding ability. 4 , 5 Among them, lncRNAs are non-coding RNAs greater than 200 nucleotides in length, and plentiful researches have reported that lncRNAs can affect growth, angiogenesis, cycle and apoptosis, autophagy, migration and invasion, and metabolism in different tumors. 6–9 As an example, lncRNA PVT1 activated STAT3/VEGFA signal pathway to induce angiogenesis 10 and enhances the progression of gastric cancer by the downregulation of p15 and p16. 11 LncRNA FOXD1-AS1 boosts glycolysis of nasopharyngeal carcinoma by the regulation of related glycolytic genes 12 and regulates the growth and metastasis of glioma via miR339/342-eIF5a axis. 13 Likewise, the functions of lncRNAs in PCa have also been largely reported. For instance, lncRNA LEF1-AS1 upgrades androgen-independent PCa progression via the upregulation of FZD2 and CD44 14 and lncRNA HOTAIR advances the invasion and metastasis of PCa by activating MAPK pathway. 15 LncRNA AATBC (apoptosis-associated transcript in bladder cancer, LOC284837) firstly was reported in bladder cancer, and knockdown of lncRNA AATBC inhibited proliferation and induced apoptosis in bladder cancer. 16 In addition, Tang et al found lncRNA AATBC promoted growth and metastasis of nasopharyngeal carcinoma. 17 However, the character of AATBC in PCa is still undefined. Consequently, we probed into the action and potential molecular mechanism of AATBC in PCa. The -Abstract Truncated-
oncology